Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Artificial intelligence as medical device in radiology in 2025: the regulatory scenario in the EU, USA, and China.

PMID: 41832928 · 2026

JournalEuropean radiology
Year2026
PMID41832928

Abstract

In the last decade, advanced AI methods were applied to radiology, providing tools for clinical practice. Regulations across countries are a relevant topic, considering that AI tools must be regarded as medical devices. We describe the regulatory scenarios in the EU, USA, and China. For the EU, we considered the 2017 Medical Device Regulation, including AI tools as "active" medical devices, the 2018 General Data Protection Regulation, protecting data privacy, and the risk-based approach by the 2

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.